Author: Shuya Lu; Qi Zhou; Liping Huang; Qianling Shi; Siya Zhao; Zijun Wang; Weiguo Li; Yuyi Tang; Yanfang Ma; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen; Chenyan Zhou; Donghong Peng
Title: Effectiveness and Safety of Glucocorticoids to Treat COVID-19: A Rapid Review and Meta-Analysis Document date: 2020_4_22
ID: 935r7w01_4
Snippet: There are conflicting opinions about the use of glucocorticoids to treat patients with It is suggested that current clinical evidence does not support the use of glucocorticoids, which may cause several side effects (8) (9) . However, clinicians who are on the front line of the epidemic have proposed that short-term glucocorticoid therapy with small or medium dose could be beneficial for patients with severe conditions (10) . The current guidelin.....
Document: There are conflicting opinions about the use of glucocorticoids to treat patients with It is suggested that current clinical evidence does not support the use of glucocorticoids, which may cause several side effects (8) (9) . However, clinicians who are on the front line of the epidemic have proposed that short-term glucocorticoid therapy with small or medium dose could be beneficial for patients with severe conditions (10) . The current guidelines on COVID-19 are also inconsistent about the use of glucocorticoids. Some guidelines suggested trying short-term therapy with medium or small doses of glucocorticoids for patients with rapid or severe disease progression, but according to the WHO guidelines glucocorticoids should only be used under clinical trial conditions (11) (12) (13) . Effective evidence related to glucocorticoids to treat COVID-19 is still lacking.
Search related documents:
Co phrase search for related documents- clinical evidence and current guideline: 1, 2, 3
- clinical evidence and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- clinical evidence and effective evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- clinical evidence and epidemic line: 1
- clinical evidence and glucocorticoid therapy: 1, 2
- clinical evidence and patient treat: 1, 2
- clinical evidence and severe condition: 1, 2, 3, 4
- clinical evidence and short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- clinical evidence and short term therapy: 1, 2, 3, 4
- clinical evidence and trial condition: 1
- clinical trial condition and trial condition: 1, 2, 3
- current clinical evidence and effective evidence: 1, 2, 3
- current clinical evidence and short term: 1
- current guideline and disease progression: 1
- current guideline and short term: 1
- disease progression and effective evidence: 1, 2, 3, 4, 5, 6, 7
- disease progression and epidemic line: 1, 2
- disease progression and glucocorticoid therapy: 1, 2, 3
- disease progression and patient treat: 1, 2
Co phrase search for related documents, hyperlinks ordered by date